Scope of application of the ursodeoxycholic acid at gastroenterological pathology
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
The article presents modern concepts on the using of ursodeoxycholic acid in the clinical practice of internist. The presented review is focused on the effects of ursodeoxycholic acid, the current spectrum of it’s application in the treatment of the patients with gastroenterological pathology, in particular, gastroesophageal reflux disease, non-alcoholic fatty liver disease, autoimmune hepatobiliary processes, chronic hepatitis, intestinal dysbiosis. The literature review has covered the historical data on the release of ursodeoxycholic acid, the first studies on the results of this drug using, and listed the ursodeoxycholic acid effects and scope of application. The literature review presents data from the global studies of the ursodeoxychloric acid effects on patients with the above listed nosology. The efficacy of its preparation has been proved in terms of reduction of the clinical manifestations of intrahepatic cholestasis in pregnant women without side effects. The presented data showed the survival prolongation in patients with primary biliary cholangitis against the background of ursodeoxychloric acid administration. It has been emphasized that long-term use of ursodeoxycholic acid at viral hepatitis, along with etiotropic therapy, allowed to eliminate the clinical manifestations and to avoid the development of complications. It was demonstrated that ursodeoxycholic acid has protective properties against the damaging effect of bile acids on the esophagus walls at gastroesophageal reflux disease. The data have been presented on the UCDA positive effects on the lipid spectrum in patients with non-alcoholic fatty liver disease. The data illustrating the significant positive differences in the composition and function of the microbiome after prolonged use of ursodeoxycholic acid have been outlined.
Authors and Affiliations
L. V. Zhuravlyova, O. V. Ogneva
Keywords
Related Articles
- EP ID EP575139
- DOI 10.30978/MG-2019-2-66
- Views 114
- Downloads 0
The new possibilities for the treatment of patients with chronic constipation
Objective — to analyze the efficacy of using the herbal drug EasyDo in patients with chronic constipation. Materials and methods. The observations involved 40 patients with chronic constipation, aged 18 to 65 years, who...
Basal and postprandial levels of ghrelin and the nature of eating behaviour in patients with irritable bowel syndrome with constipation against the background of various degrees of obesity
Objective — to study the basal and postprandial serum levels of ghrelin, its association with types of eating behaviour and the appearance of constipation in patients with irritable bowel syndrome against the background...
Deep cystic gastritis: literature review and clinical case
The article presents the overview of recent literature data on a rare variant of chronic gastritis, deep cystic gastritis (gastritis cysticaprofunda). In the most cases, this disease is diagnosed histologically in patien...
United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
-
Clinical case of compensatory nodular hyperplasia
Despite the fact the benign liver neoplasms are relatively rare diseases, a clinician should be aware of such typical benign liver damage as focal nodular hyperplasia (FNH). The article presents a case report of a 36-yea...